
Aveanna Healthcare rose 46.9% from $8.98 to $13.19, ahead of the S&P 500's +9.8%. Its worst day was Mar 19 (−8.2%), and its low came Apr 10 at $6.22.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Aveanna Healthcare shares rose 10.0%, while the S&P 500 fell 0.5%.
+10.0% · S&P 500 −0.5%
Story events cover the past 12 months · Times ET
EPS of $0.17 beat the $0.13 estimate on $662.5M revenue (est. $640.5M); FY revenue guidance of $2.5B–$2.6B against the $2.6B consensus.
−8.2%, the year's worst day · S&P 500 −0.5%
Aveanna Healthcare closed at its lowest level of the year, 30.7% below where the year started.
−5.9% · S&P 500 −0.1%
EPS of $0.18 beat the $0.13 estimate on $647.9M revenue (est. $613.9M); FY revenue guidance of $2.6B–$2.6B against the $2.6B consensus.
+9.9% · S&P 500 +0.8%
EPS of $0.22 beat the $0.17 estimate on $670.5M revenue (est. $640.3M); FY revenue guidance of $2.7B against the $2.6B consensus.
+24.8%, the year's best day, on 10M shares, the year's heaviest volume · S&P 500 +0.7%
Aveanna Healthcare closed at its highest level of the year, 60.1% above where the year started.
+2.1% · S&P 500 −0.4%
Where it ended: a close of $13.19 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $0.20, revenue est. $681.1M).
Nothing in the past 12 months.
All AVAH dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AVAH and SPY from Benzinga historical bars. Not investment advice.